{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:32:12Z","timestamp":1791685932928,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.xphs.2020.12.033","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T20:18:50Z","timestamp":1609359530000},"page":"2423-2431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation"],"prefix":"10.1016","volume":"110","author":[{"given":"Sonal V.","family":"Bhujbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry Y.","family":"Zemlyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi (Tony)","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.xphs.2020.12.033_bib1","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","article-title":"Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs","volume":"105","author":"Baghel","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2020.12.033_bib2","first-page":"41","article-title":"Solubility enhancement techniques","volume":"5","author":"Vemula","year":"2010","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.12.033_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpharm.2012.08.014","article-title":"Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement","volume":"437","author":"Frank","year":"2012","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2020.12.033_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","article-title":"Pharmaceutical applications of solid dispersion systems","volume":"60","author":"Chiou","year":"1971","journal-title":"J\u00a0Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2020.12.033_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/js980403l","article-title":"Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs","volume":"88","author":"Serajuddin","year":"1999","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2020.12.033_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0928-0987(00)00173-1","article-title":"Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25","volume":"12","author":"Van den Mooter","year":"2001","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2020.12.033_bib7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1023\/A:1015834715152","article-title":"The relationship between the glass transition temperature and water vapor absorption by poly (vinylpyrrolidone)","volume":"7","author":"Oksanen","year":"1990","journal-title":"Pharm Res (N Y)"},{"issue":"6","key":"10.1016\/j.xphs.2020.12.033_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1248\/cpb.50.822","article-title":"Effect of water on the molecular mobility of sucrose and poly (vinylpyrrolidone) in a colyophilized formulation as measured by 13C-NMR relaxation time","volume":"50","author":"Aso","year":"2002","journal-title":"Chem Pharm Bull"},{"issue":"12","key":"10.1016\/j.xphs.2020.12.033_bib9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1023\/A:1012167410376","article-title":"Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions","volume":"14","author":"Taylor","year":"1997","journal-title":"Pharm Res (N Y)"},{"issue":"11","key":"10.1016\/j.xphs.2020.12.033_bib10","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/jps.20182","article-title":"Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen","volume":"93","author":"Miyazaki","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.12.033_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jps.20545","article-title":"Molecular mobility of nifedipine\u2212 PVP and phenobarbital\u2212 PVP solid dispersions as measured by 13C-NMR spin-lattice relaxation time","volume":"95","author":"Aso","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2020.12.033_bib12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s11095-006-9047-9","article-title":"A\u00a0comparison of the physical stability of amorphous felodipine and nifedipine systems","volume":"23","author":"Marsac","year":"2006","journal-title":"Pharm Res (N Y)"},{"issue":"2","key":"10.1016\/j.xphs.2020.12.033_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejpb.2008.05.023","article-title":"Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine","volume":"70","author":"Konno","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2020.12.033_bib14","series-title":"Achieving a Hot Melt Extrusion Design Space for the Production of Solid Solutions","first-page":"469","author":"Schenck","year":"2019"},{"issue":"7","key":"10.1016\/j.xphs.2020.12.033_bib15","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s11095-015-1638-x","article-title":"An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy","volume":"32","author":"Keratichewanun","year":"2015","journal-title":"Pharm Res (N Y)"},{"issue":"1","key":"10.1016\/j.xphs.2020.12.033_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1208\/s12249-013-9931-7","article-title":"Amorphous solid dispersions of sulfonamide\/Soluplus\u00ae and sulfonamide\/PVP prepared by ball milling","volume":"14","author":"Caron","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2020.12.033_bib17","first-page":"100035","article-title":"Amorphous solid dispersion formation via solvent granulation\u2013A case study with ritonavir and lopinavir","volume":"1","author":"Trasi","year":"2019","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.xphs.2020.12.033_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2015.12.010","article-title":"Spray drying formulation of amorphous solid dispersions","volume":"100","author":"Singh","year":"2016","journal-title":"Adv Drug Del Rev"},{"issue":"3","key":"10.1016\/j.xphs.2020.12.033_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejps.2012.12.012","article-title":"Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug\u2013polymer interactions on supersaturation","volume":"48","author":"Sarode","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.12.033_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cis.2015.05.003","article-title":"Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers","volume":"223","author":"Sosnik","year":"2015","journal-title":"Adv Colloid Interface Sci"},{"issue":"10","key":"10.1016\/j.xphs.2020.12.033_bib21","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1248\/cpb.26.3033","article-title":"Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate","volume":"26","author":"Sekikawa","year":"1978","journal-title":"Chem Pharm Bull"},{"issue":"5","key":"10.1016\/j.xphs.2020.12.033_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jps.2600580503","article-title":"Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates","volume":"58","author":"Simonelli","year":"1969","journal-title":"J\u00a0Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.12.033_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-5173(02)00331-9","article-title":"Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation","volume":"245","author":"Sertsou","year":"2002","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.12.033_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2013.04.040","article-title":"Highly efficient miniaturized coprecipitation screening (MiCoS) for amorphous solid dispersion formulation development","volume":"450","author":"Hu","year":"2013","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.12.033_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2007.12.017","article-title":"Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation","volume":"355","author":"Dong","year":"2008","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2020.12.033_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1211\/002235702320266181","article-title":"Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug","volume":"54","author":"Sertsou","year":"2002","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2020.12.033_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jddst.2019.03.012","article-title":"Co-precipitation of calcium carbonate and curcumin in an ethanol medium as a novel approach for curcumin dissolution enhancement","volume":"51","author":"Zhou","year":"2019","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2020.12.033_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.23425","article-title":"Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process","volume":"102","author":"Shah","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.12.033_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2012.08.031","article-title":"Development of novel microprecipitated bulk powder (MBP) technology for manufacturing stable amorphous formulations of poorly soluble drugs","volume":"438","author":"Shah","year":"2012","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2020.12.033_bib30","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s11095-009-9974-3","article-title":"Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions","volume":"26","author":"Rumondor","year":"2009","journal-title":"Pharm Res (N Y)"},{"issue":"4","key":"10.1016\/j.xphs.2020.12.033_bib31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1208\/s12249-011-9686-y","article-title":"Understanding the tendency of amorphous solid dispersions to undergo amorphous\u2013amorphous phase separation in the presence of absorbed moisture","volume":"12","author":"Rumondor","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2020.12.033_bib32","first-page":"27","article-title":"Design and evaluation of Lumefantrine\u2013Oleic acid self nanoemulsifying ionic complex for enhanced dissolution","volume":"21","author":"Patel","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.12.033_bib33","first-page":"139","article-title":"First case of treatment failure of artemether-lumefantrine in a Japanese traveler with imported falciparum malaria","volume":"62","author":"Mizuno","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.xphs.2020.12.033_bib34","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2011.041","article-title":"Possible clinical failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria","volume":"3","author":"Repetto","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.xphs.2020.12.033_bib35","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/acs.molpharmaceut.0c00108","article-title":"In\u00a0vitro and in\u00a0vivo behavior of KinetiSol\u00ae and spray dried amorphous solid dispersions of a weakly basic drug and ionic polymer","volume":"17","author":"Jermain","year":"2020","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2020.12.033_bib36","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.xphs.2016.03.024","article-title":"Non-sink dissolution conditions for predicting product quality and in\u00a0vivo performance of supersaturating drug delivery systems","volume":"105","author":"Sun","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.12.033_bib37","first-page":"201","article-title":"Simultaneous HPLC-UV method for the estimation of artemether and lumefantrine in tablet dosage form","volume":"2","author":"Arun","year":"2011","journal-title":"Int J Pharm Biomed Res"},{"issue":"2","key":"10.1016\/j.xphs.2020.12.033_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijpharm.2016.06.126","article-title":"Acid-base interactions in amorphous solid dispersions of lumefantrine prepared by spray-drying and hot-melt extrusion using X-ray photoelectron spectroscopy","volume":"514","author":"Song","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2020.12.033_bib39","first-page":"100052","article-title":"Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach","volume":"X","author":"Trasi","year":"2020","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2020.12.033_bib40","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/jps.2600831211","article-title":"Crystallization of indomethacin from the amorphous state below and above its glass transition temperature","volume":"83","author":"Yoshioka","year":"1994","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2020.12.033_bib41","doi-asserted-by":"crossref","first-page":"119560","DOI":"10.1016\/j.ijpharm.2020.119560","article-title":"Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products","volume":"586","author":"Pandi","year":"2020","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2020.12.033_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4172\/pharmaceutical-sciences.1000279","article-title":"Enhancement of the solubility of poorly water soluble drugs through solid dispersion: a comprehensive review","volume":"79","author":"Singh","year":"2017","journal-title":"Indian J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2020.12.033_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1023\/A:1018941810744","article-title":"The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids","volume":"11","author":"Hancock","year":"1994","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.xphs.2020.12.033_bib44","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1021\/acs.molpharmaceut.0c00798","article-title":"Water-induced phase separation of spray dried amorphous solid dispersions","volume":"17","author":"Li","year":"2020","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2020.12.033_bib45","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/mp500692a","article-title":"Investigation of drug\u2013excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy","volume":"12","author":"Song","year":"2015","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2020.12.033_bib46","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.22074","article-title":"Drug\u2013polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development","volume":"99","author":"Qian","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2020.12.033_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.xphs.2017.07.001","article-title":"Producing amorphous solid dispersions via co-precipitation and spray drying: impact to physicochemical and biopharmaceutical properties","volume":"107","author":"Mann","year":"2018","journal-title":"J\u00a0Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920308467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920308467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:32:17Z","timestamp":1758360737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920308467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022354920308467"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.12.033","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}]}}